My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Livewire Live
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Livewire Live
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
NDF Research
Latest news and analysis on NDF Research
September 07, 2016 19:16
Botanix Pharmaceuticals (ASX: BOT) - Management that have done it before
Stuart Roberts
Pitt Street Research and NDF Research
September 07, 2016 19:16
September 06, 2016 06:41
Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback
Stuart Roberts
Pitt Street Research and NDF Research
September 06, 2016 06:41
September 05, 2016 11:14
Cynata (ASX: CYP) - Australian stem-cell know-how gets picked up in Japan
Stuart Roberts
Pitt Street Research and NDF Research
September 05, 2016 11:14
Advertisement
September 05, 2016 10:34
Sirtex (ASX: SRX) - A therapy going mainstream
Stuart Roberts
Pitt Street Research and NDF Research
September 05, 2016 10:34
September 02, 2016 07:20
AirXpanders (ASX: AXP) - Big step forward for patients, potentially big money for investors
Stuart Roberts
Pitt Street Research and NDF Research
September 02, 2016 07:20
September 01, 2016 07:22
Starpharma (ASX:SPL) - It's big business putting new life into old drugs
Stuart Roberts
Pitt Street Research and NDF Research
September 01, 2016 07:22
August 26, 2016 16:10
The Coming Boom in Life Sciences in Australia
Stuart Roberts
Pitt Street Research and NDF Research
August 26, 2016 16:10
41-47 of 47
1
2
3
4
5
most
popular
Reporting Season
The Australian share market is broken
Rudi Filapek-Vandyck,
FNArena
Equities
Is 4D Medical the real deal? CEO Dr Andreas Fouras makes his
case
Chris Conway,
Livewire Markets
Reporting Season
Wild swings, big opportunities: 6 ASX best ideas Morgans is backing
Vishal Teckchandani,
Livewire Markets
Buy Hold Sell
Buy Hold Sell: 6 ASX large cap leaders and
laggards
Tom Stelzer,
Livewire Markets
view all
Advertisement
